{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:38:53Z","timestamp":1791689933243,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41417-025-00972-y","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T09:12:04Z","timestamp":1759396324000},"page":"1356-1369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Demethoxycurcumin suppresses HK2-mediated glycolysis by targeting PTEN\/Akt signaling"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8377-8269","authenticated-orcid":false,"given":"Jinzhuang","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangze","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7267-6494","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"972_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15:44.","journal-title":"Int J Oral Sci"},{"key":"972_CR2","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1111\/add.15513","volume":"116","author":"PJ Ford","year":"2021","unstructured":"Ford PJ, Rich AM. Tobacco Use and Oral Health. Addiction. 2021;116:3531\u201340.","journal-title":"Addiction"},{"key":"972_CR3","first-page":"645","volume":"156","author":"Y Ghantous","year":"2017","unstructured":"Ghantous Y, Abu Elnaaj I. [Global Incidence And Risk Factors Of Oral Cancer]. Harefuah. 2017;156:645\u20139.","journal-title":"Harefuah"},{"key":"972_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.radonc.2020.08.013","volume":"154","author":"A Hosni","year":"2021","unstructured":"Hosni A, Chiu K, Huang SH, Xu W, Huang J, Bayley A, et al. Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach. Radiother Oncol. 2021;154:70\u20135.","journal-title":"Radiother Oncol"},{"key":"972_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33080-8","volume":"13","author":"WT Ju","year":"2022","unstructured":"Ju WT, Xia RH, Zhu DW, Dou SJ, Zhu GP, Dong MJ, et al. A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nat Commun. 2022;13:5378.","journal-title":"Nat Commun"},{"key":"972_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1200\/JCO.2012.43.8820","volume":"31","author":"LP Zhong","year":"2013","unstructured":"Zhong LP, Zhang CP, Ren GX, Guo W, William WN Jr., Sun J, et al. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 2013;31:744\u201351.","journal-title":"J Clin Oncol"},{"key":"972_CR7","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S, Kumar S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 2022;86:1216\u201330.","journal-title":"Semin Cancer Biol"},{"key":"972_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22163-7","volume":"12","author":"X Shangguan","year":"2021","unstructured":"Shangguan X, He J, Ma Z, Zhang W, Ji Y, Shen K, et al. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat Commun. 2021;12:1812.","journal-title":"Nat Commun"},{"key":"972_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tibs.2018.01.006","volume":"43","author":"Z Lu","year":"2018","unstructured":"Lu Z, Hunter T. Metabolic Kinases Moonlighting as Protein Kinases. Trends Biochem Sci. 2018;43:301\u201310.","journal-title":"Trends Biochem Sci"},{"key":"972_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s41401-024-01264-1","volume":"45","author":"X Ni","year":"2024","unstructured":"Ni X, Lu CP, Xu GQ, Ma JJ. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy. Acta Pharm Sin. 2024;45:1533\u201355.","journal-title":"Acta Pharm Sin"},{"key":"972_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07137-z","volume":"15","author":"T Xia","year":"2024","unstructured":"Xia T, Meng L, Xu G, Sun H, Chen H. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. Cell Death Dis. 2024;15:740.","journal-title":"Cell Death Dis"},{"key":"972_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105126","volume":"9","author":"H Li","year":"2022","unstructured":"Li H, Song J, He Y, Liu Y, Liu Z, Sun W, et al. CRISPR\/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4-Fatty Acid \u03b2-Oxidation Pathway. Adv Sci (Weinh). 2022;9:e2105126.","journal-title":"Adv Sci (Weinh)"},{"key":"972_CR13","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41556-023-01185-x","volume":"25","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiang C, Zhong Y, Sun K, Jing H, Song J, et al. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2. Nat Cell Biol. 2023;25:1208\u201322.","journal-title":"Nat Cell Biol"},{"key":"972_CR14","doi-asserted-by":"publisher","first-page":"19320","DOI":"10.1002\/jcp.28626","volume":"234","author":"M Hatamipour","year":"2019","unstructured":"Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Sahebkar A. Demethoxycurcumin: A naturally occurring curcumin analogue for treating non-cancerous diseases. J Cell Physiol. 2019;234:19320\u201330.","journal-title":"J Cell Physiol"},{"key":"972_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108914","volume":"108","author":"B Lu","year":"2022","unstructured":"Lu B, Chen X, Chen H, Li Q, Li H, Xu Y, et al. Demethoxycurcumin mitigates inflammatory responses in lumbar disc herniation via MAPK and NF-\u03baB pathways in vivo and in vitro. Int Immunopharmacol. 2022;108:108914.","journal-title":"Int Immunopharmacol"},{"key":"972_CR16","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1002\/jcp.27029","volume":"233","author":"M Hatamipour","year":"2018","unstructured":"Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Ramezani M, Sahebkar A. Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties. J Cell Physiol. 2018;233:9247\u201360.","journal-title":"J Cell Physiol"},{"key":"972_CR17","first-page":"1331","volume":"55","author":"J Tang","year":"2023","unstructured":"Tang J, Peng H, Xu F, Luo P, Liu D, Chen L. Demethoxycurcumin represses cervical cancer growth through PPAR\u03b3-regulated proliferation and apoptosis. Acta Biochim Biophys Sin (Shanghai). 2023;55:1331\u20133.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"972_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/mmr.2017.6666","volume":"16","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhang P, Yang H, Ge Y, Xin Y. Effects of demethoxycurcumin on the viability and apoptosis of skin cancer cells. Mol Med Rep. 2017;16:539\u201346.","journal-title":"Mol Med Rep"},{"key":"972_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1021\/jf5042307","volume":"63","author":"YN Teng","year":"2015","unstructured":"Teng YN, Hsieh YW, Hung CC, Lin HY. Demethoxycurcumin modulates human P-glycoprotein function via uncompetitive inhibition of ATPase hydrolysis activity. J Agric Food Chem. 2015;63:847\u201355.","journal-title":"J Agric Food Chem"},{"key":"972_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12906-020-2857-1","volume":"20","author":"C Huang","year":"2020","unstructured":"Huang C, Lu HF, Chen YH, Chen JC, Chou WH, Huang HC. Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and -independent apoptosis via Smad or Akt signaling pathways in HOS cells. BMC Complement Med Ther. 2020;20:68.","journal-title":"BMC Complement Med Ther"},{"key":"972_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2579-9","volume":"11","author":"M Li","year":"2020","unstructured":"Li M, Gao F, Zhao Q, Zuo H, Liu W, Li W. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis. Cell Death Dis. 2020;11:381.","journal-title":"Cell Death Dis"},{"key":"972_CR22","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.7150\/jca.85011","volume":"14","author":"M Li","year":"2023","unstructured":"Li M, Zhao Q, Liao J, Wang X, Liu L, Zhang X, et al. Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells. J Cancer. 2023;14:2027\u201338.","journal-title":"J Cancer"},{"key":"972_CR23","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1142\/S0192415X23500957","volume":"51","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Han S, Liao J, Wang R, Yu X, Li M. Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin. Am J Chin Med. 2023;51:2221\u201341.","journal-title":"Am J Chin Med"},{"key":"972_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7150\/ijbs.87180","volume":"20","author":"J Liao","year":"2024","unstructured":"Liao J, Qing X, Li X, Gan Y, Wang R, Han S, et al. TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance. Int J Biol Sci. 2024;20:182\u201399.","journal-title":"Int J Biol Sci"},{"key":"972_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110851","volume":"110","author":"J Liao","year":"2023","unstructured":"Liao J, Qing X, Deng G, Xiao Y, Fu Y, Han S, et al. Gastrodin destabilizes survivin and overcomes pemetrexed resistance. Cell Signal. 2023;110:110851.","journal-title":"Cell Signal"},{"key":"972_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41420-023-01648-y","volume":"9","author":"L Xie","year":"2023","unstructured":"Xie L, Liao J, Liu W, Wang R, Li X, Li W, et al. Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis. Cell Death Discov. 2023;9:364.","journal-title":"Cell Death Discov"},{"key":"972_CR27","doi-asserted-by":"publisher","first-page":"826","DOI":"10.7150\/ijbs.31749","volume":"15","author":"L Zhou","year":"2019","unstructured":"Zhou L, Li M, Yu X, Gao F, Li W. Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells. Int J Biol Sci. 2019;15:826\u201337.","journal-title":"Int J Biol Sci"},{"key":"972_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2344-0","volume":"11","author":"F Gao","year":"2020","unstructured":"Gao F, Yu X, Li M, Zhou L, Liu W, Li W, et al. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3\u03b2\/FBW7-mediated Mcl-1 destabilization. Cell Death Dis. 2020;11:143.","journal-title":"Cell Death Dis"},{"key":"972_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200\u201316.","journal-title":"Nat Rev Drug Discov"},{"key":"972_CR30","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. Int J Biol Sci. 2024;20:3113\u201325.","journal-title":"Int J Biol Sci"},{"key":"972_CR31","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","volume":"64","author":"RL Elstrom","year":"2004","unstructured":"Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004;64:3892\u20139.","journal-title":"Cancer Res"},{"key":"972_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114865","volume":"163","author":"S Li","year":"2023","unstructured":"Li S, Wang D, Zheng X, Li Y, Ding C, Wang M, et al. Combination of niclosamide and quinacrine inactivates Akt\/HK2\/Cyclin D1 axis mediated by glucose deprivation towards the inhibition of melanoma cell proliferation. Biomed Pharmacother. 2023;163:114865.","journal-title":"Biomed Pharmacother"},{"key":"972_CR33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.1175065","volume":"325","author":"WL Yang","year":"2009","unstructured":"Yang WL, Wang J, Chan CH, Lee SW, Campos AD, Lamothe B, et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science. 2009;325:1134\u20138.","journal-title":"Science"},{"key":"972_CR34","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2012.02.065","volume":"149","author":"CH Chan","year":"2012","unstructured":"Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell. 2012;149:1098\u2013111.","journal-title":"Cell"},{"key":"972_CR35","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1158\/0008-5472.CAN-13-0913","volume":"73","author":"W Li","year":"2013","unstructured":"Li W, Peng C, Lee MH, Lim D, Zhu F, Fu Y, et al. TRAF4 is a critical molecule for Akt activation in lung cancer. Cancer Res. 2013;73:6938\u201350.","journal-title":"Cancer Res"},{"key":"972_CR36","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/ncb2874","volume":"15","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang P, Wei Y, Piao HL, Wang W, Maddika S, et al. Deubiquitylation and stabilization of PTEN by USP13. Nat Cell Biol. 2013;15:1486\u201394.","journal-title":"Nat Cell Biol"},{"key":"972_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"972_CR38","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.7150\/ijbs.93943","volume":"20","author":"HL Yang","year":"2024","unstructured":"Yang HL, Chang CW, Vadivalagan C, Pandey S, Chen SJ, Lee CC, et al. Coenzyme Q(0) inhibited the NLRP3 inflammasome, metastasis\/EMT, and Warburg effect by suppressing hypoxia-induced HIF-1\u03b1 expression in HNSCC cells. Int J Biol Sci. 2024;20:2790\u2013813.","journal-title":"Int J Biol Sci"},{"key":"972_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang CH, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23:203.","journal-title":"Mol Cancer"},{"key":"972_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13046-020-01765-x","volume":"39","author":"L Cao","year":"2020","unstructured":"Cao L, Wu J, Qu X, Sheng J, Cui M, Liu S, et al. Glycometabolic rearrangements-aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications. J Exp Clin Cancer Res. 2020;39:267.","journal-title":"J Exp Clin Cancer Res"},{"key":"972_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.7150\/ijbs.57919","volume":"18","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Yang K, Liu P, Ma D, Lei P, Liu Q. Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism. Int J Biol Sci. 2022;18:82\u201395.","journal-title":"Int J Biol Sci"},{"key":"972_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2024.03.001","volume":"100","author":"D Yadav","year":"2024","unstructured":"Yadav D, Yadav A, Bhattacharya S, Dagar A, Kumar V, Rani R. GLUT and HK: Two primary and essential key players in tumor glycolysis. Semin Cancer Biol. 2024;100:17\u201327.","journal-title":"Semin Cancer Biol"},{"key":"972_CR43","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.7150\/ijbs.79583","volume":"19","author":"Y Guan","year":"2023","unstructured":"Guan Y, Yao W, Yu H, Feng Y, Zhao Y, Zhan X, et al. Chronic stress promotes colorectal cancer progression by enhancing glycolysis through \u03b22-AR\/CREB1 signal pathway. Int J Biol Sci. 2023;19:2006\u201319.","journal-title":"Int J Biol Sci"},{"key":"972_CR44","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.7150\/ijbs.93462","volume":"20","author":"DY Sim","year":"2024","unstructured":"Sim DY, Lee HJ, Ahn CH, Park J, Park SY, Kil BJ, et al. Negative Regulation of CPSF6 Suppresses the Warburg Effect and Angiogenesis Leading to Tumor Progression Via c-Myc Signaling Network: Potential Therapeutic Target for Liver Cancer Therapy. Int J Biol Sci. 2024;20:3442\u201360.","journal-title":"Int J Biol Sci"},{"key":"972_CR45","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fonc.2019.01446","volume":"9","author":"H Cai","year":"2019","unstructured":"Cai H, Li J, Zhang Y, Liao Y, Zhu Y, Wang C, et al. LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial-Mesenchymal Transition. Front Oncol. 2019;9:1446.","journal-title":"Front Oncol"},{"key":"972_CR46","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.18632\/oncotarget.13763","volume":"8","author":"W Wang","year":"2017","unstructured":"Wang W, Liu Z, Zhao L, Sun J, He Q, Yan W, et al. Hexokinase 2 enhances the metastatic potential of tongue squamous cell carcinoma via the SOD2-H2O2 pathway. Oncotarget. 2017;8:3344\u201354.","journal-title":"Oncotarget"},{"key":"972_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06009-2","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhan Y, Zhang Y, Zhang Y, Liu Y, Xie Y, et al. Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2. Cell Death Dis. 2023;14:488.","journal-title":"Cell Death Dis"},{"key":"972_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0947-9","volume":"18","author":"J Chen","year":"2019","unstructured":"Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143\/HK2 axis in gallbladder cancer. Mol Cancer. 2019;18:33.","journal-title":"Mol Cancer"},{"key":"972_CR49","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/cac2.12351","volume":"42","author":"J Wang","year":"2022","unstructured":"Wang J, Shao F, Yang Y, Wang W, Yang X, Li R, et al. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability. Cancer Commun (Lond). 2022;42:1008\u201327.","journal-title":"Cancer Commun (Lond)"},{"key":"972_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10239-6","volume":"22","author":"S Kim","year":"2022","unstructured":"Kim S, Koh J, Song SG, Yim J, Kim M, Keam B, et al. High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+\/regulatory T-cell infiltration. BMC Cancer. 2022;22:1120.","journal-title":"BMC Cancer"},{"key":"972_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04727-7","volume":"13","author":"J Tantai","year":"2022","unstructured":"Tantai J, Pan X, Chen Y, Shen Y, Ji C. TRIM46 activates AKT\/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells. Cell Death Dis. 2022;13:285.","journal-title":"Cell Death Dis"},{"key":"972_CR52","doi-asserted-by":"publisher","first-page":"32332","DOI":"10.18632\/oncotarget.15974","volume":"8","author":"J Wu","year":"2017","unstructured":"Wu J, Hu L, Wu F, Zou L, He T. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis. Oncotarget. 2017;8:32332\u201344.","journal-title":"Oncotarget"},{"key":"972_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06890-5","volume":"15","author":"L Zhao","year":"2024","unstructured":"Zhao L, Yu N, Zhai Y, Yang Y, Wang Y, Yang Y, et al. The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis. Cell Death Dis. 2024;15:502.","journal-title":"Cell Death Dis"},{"key":"972_CR54","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.7150\/ijbs.56357","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Sun N, Li R, Sang X, Li X, Zhao J, et al. Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis. Int J Biol Sci. 2021;17:1263\u201376.","journal-title":"Int J Biol Sci"},{"key":"972_CR55","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jcmm.17687","volume":"27","author":"B Liang","year":"2023","unstructured":"Liang B, Jiang Y, Song S, Jing W, Yang H, Zhao L, et al. ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT\/\u03b2-catenin\/HK2 axis. J Cell Mol Med. 2023;27:659\u201371.","journal-title":"J Cell Mol Med"},{"key":"972_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109698","volume":"254","author":"T Liu","year":"2023","unstructured":"Liu T, Wen Z, Shao L, Cui Y, Tang X, Miao H, et al. ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1\u03b1 ubiquitination in sepsis. Clin Immunol. 2023;254:109698.","journal-title":"Clin Immunol"},{"key":"972_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2336-0","volume":"11","author":"L Cao","year":"2020","unstructured":"Cao L, Wang M, Dong Y, Xu B, Chen J, Ding Y, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a\/HIF-1\u03b1\/HK2. Cell Death Dis. 2020;11:145.","journal-title":"Cell Death Dis"},{"key":"972_CR58","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.7150\/ijbs.48933","volume":"17","author":"T Liu","year":"2021","unstructured":"Liu T, Ye P, Ye Y, Han B. MicroRNA-216b targets HK2 to potentiate autophagy and apoptosis of breast cancer cells via the mTOR signaling pathway. Int J Biol Sci. 2021;17:2970\u201383.","journal-title":"Int J Biol Sci"},{"key":"972_CR59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:126.","journal-title":"J Exp Clin Cancer Res"},{"key":"972_CR60","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13046-022-02528-6","volume":"41","author":"L Zhao","year":"2022","unstructured":"Zhao L, Kang M, Liu X, Wang Z, Wang Y, Chen H, et al. UBR7 inhibits HCC tumorigenesis by targeting Keap1\/Nrf2\/Bach1\/HK2 and glycolysis. J Exp Clin Cancer Res. 2022;41:330.","journal-title":"J Exp Clin Cancer Res"},{"key":"972_CR61","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1111\/cas.15763","volume":"114","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhou T, Wang Y, Bao M, Ni C, Ding L, et al. Trigred motif 36 regulates neuroendocrine differentiation of prostate cancer via HK2 ubiquitination and GPx4 deficiency. Cancer Sci. 2023;114:2445\u201359.","journal-title":"Cancer Sci"},{"key":"972_CR62","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s13402-023-00850-5","volume":"46","author":"X Li","year":"2023","unstructured":"Li X, Liang Q, Zhou L, Deng G, Xiao Y, Gan Y, et al. Survivin degradation by bergenin overcomes pemetrexed resistance. Cell Oncol (Dordr). 2023;46:1837\u201353.","journal-title":"Cell Oncol (Dordr)"},{"key":"972_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05343-1","volume":"13","author":"J Sarkar","year":"2022","unstructured":"Sarkar J, Das M, Howlader MSI, Prateeksha P, Barthels D, Das H. Epigallocatechin-3-gallate inhibits osteoclastic differentiation by modulating mitophagy and mitochondrial functions. Cell Death Dis. 2022;13:908.","journal-title":"Cell Death Dis"},{"key":"972_CR64","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7150\/ijbs.65019","volume":"18","author":"X Yan","year":"2022","unstructured":"Yan X, Yao C, Fang C, Han M, Gong C, Hu D, et al. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci. 2022;18:585\u201398.","journal-title":"Int J Biol Sci"},{"key":"972_CR65","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.7150\/ijbs.87829","volume":"20","author":"S Yu","year":"2024","unstructured":"Yu S, Deng R, Wang W, Zou D, He L, Wei Z, et al. Pharmacological manipulation of TRPC5 by kaempferol attenuates metastasis of gastrointestinal cancer via inhibiting calcium involved in the formation of filopodia. Int J Biol Sci. 2024;20:4922\u201340.","journal-title":"Int J Biol Sci"},{"key":"972_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06902-4","volume":"15","author":"M Mansuer","year":"2024","unstructured":"Mansuer M, Zhou L, Wang C, Gao L, Jiang Y. Erianin induces ferroptosis in GSCs via REST\/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance. Cell Death Dis. 2024;15:522.","journal-title":"Cell Death Dis"},{"key":"972_CR67","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.phymed.2018.08.005","volume":"53","author":"CY Lin","year":"2019","unstructured":"Lin CY, Hung CC, Wang CCN, Lin HY, Huang SH, Sheu MJ. Demethoxycurcumin sensitizes the response of non-small cell lung cancer to cisplatin through downregulation of TP and ERCC1-related pathways. Phytomedicine. 2019;53:28\u201336.","journal-title":"Phytomedicine"},{"key":"972_CR68","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/tox.23332","volume":"36","author":"CC Kao","year":"2021","unstructured":"Kao CC, Cheng YC, Yang MH, Cha TL, Sun GH, Ho CT, et al. Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K\/Akt pathway. Environ Toxicol. 2021;36:2186\u201395.","journal-title":"Environ Toxicol"},{"key":"972_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-017-0514-4","volume":"36","author":"D Xu","year":"2017","unstructured":"Xu D, Jin J, Yu H, Zhao Z, Ma D, Zhang C, et al. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. J Exp Clin Cancer Res. 2017;36:44.","journal-title":"J Exp Clin Cancer Res"},{"key":"972_CR70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13046-017-0530-4","volume":"36","author":"W Li","year":"2017","unstructured":"Li W, Zheng M, Wu S, Gao S, Yang M, Li Z, et al. Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2. J Exp Clin Cancer Res. 2017;36:58.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00972-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00972-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T23:02:16Z","timestamp":1765753336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-025-00972-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1038\/s41417-025-00972-y","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee, the Third Xiangya Hospital of Central South University (Changsha, China). All methods were performed in accordance with the relevant guidelines and regulations. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}